Dr Reddys Laboratories Q4 Results

  • BSE: 500124
  • NSE: DRREDDY
  • ISIN: INE089A01031
  • Sector: Biotechnology & Drugs
BSE
1,209-4.90 (-0.40%)
Volume92.17 K
Updated: Mon 25 Nov, 2024 | 15:53:03
NSE
1,209.3-5.15 (-0.42%)
Volume3.28 M
Updated: Mon 25 Nov, 2024 | 15:40:52
Today: 1,205.80
1,242.15
52-Wk: 1,074.35
1,420.20

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Dr Reddys Laboratories Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 7,113.806,789.80-%6,315.20-%
    Selling/ General/ Admin Expenses Total 3,207.802,836.50-%2,829.20-%
    Depreciation/ Amortization 367.70323.70-%315.50-%
    Total Operating Expense 5,650.305,175.00-%5,096.70-%
    Operating Income 1,463.501,614.80-%1,218.50-%
    Net Income Before Taxes 1,605.201,637.70-%1,329.20-%
    Net Income 1,309.801,243.90-%960.20-%
    Diluted Normalized EPS 77.6875.37-%60.01-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts